Patent application number | Description | Published |
20100197314 | System and Method for Opportunistic Cell Edge Selection in Multi-Cell MIMO OFDMA Networks - A method for allocating resources in an orthogonal frequency division multiple access (OFDMA) network, where each cell in the network has a center region and an edge region. The cell center region uses a frequency band orthogonal to the frequency band used by the cell edge region. The frequency band is made up of resource blocks (RBs) or non-overlapping sets of subcarriers. Upon availability of cell-center RBs, cell-center user equipment (UEs) are assigned resource blocks. A fixed number of cell edge regions from a few adjacent cells form a cluster, and only the cell edge regions with the highest achievable throughput rate within each cluster gets to transmit in a given scheduling instance. | 08-05-2010 |
20110064051 | CLUSTERED MULTI-CELL MULTI-USER MULTIPLE INPUT MULTIPLE OUTPUT COMMUNICATION SYSTEM USING CELL-EDGE USER SELECTION SCHEME - Provided is a control method of a control apparatus for a multi-cell communication system including a plurality of cells, the method including determining a cell edge terminal or an inner cell terminal from each of terminals included in each of the cells, and selecting, from base stations included in the plurality of cells, a first base station and a second base station. The first base station may serve all of a corresponding cell edge terminal and a corresponding inner cell terminal, and the second base station may serve only the corresponding inner cell terminal between the corresponding cell edge terminal and the corresponding inner cell terminal. | 03-17-2011 |
20110134978 | System and Method for Non-Uniform Bit Allocation in the Quantization of Channel State Vectors - A system and method for non-uniform bit allocation in the quantization of channel state vectors is provided. A method for communications node operation includes receiving a bit-allocation profile for use in quantizing channel state information, measuring a communications channel between the communications node and a controller, generating channel state information based on the measurement, computing a bit representation of the channel state information, transmitting the bit representation to the controller, and receiving a transmission from the controller. The computing makes use of quasi-tail-biting trellis decoding, and the computing is based on the bit-allocation policy. The transmission makes use of the channel state information transmitted by the communications node. | 06-09-2011 |
20110135020 | System and Method for Quantization of Channel State Vectors - A system and method for the quantization of channel state vectors is provided. A method for communications node operation includes measuring a communications channel between the communications node and a controller, generating channel state information based on the measurement, computing a bit representation of the channel state information, transmitting the bit representation to the controller, and receiving a transmission from the controller. The computing makes use of tail-biting trellis decoding, and the transmission makes use of the channel state information transmitted by the communications node. | 06-09-2011 |
20130003808 | System and Method for Non-Uniform Bit Allocation in the Quantization of Channel State Vectors - A system and method for non-uniform bit allocation in the quantization of channel state vectors is provided. A method for communications node operation includes receiving a bit-allocation profile for use in quantizing channel state information, measuring a communications channel between the communications node and a controller, generating channel state information based on the measurement, computing a bit representation of the channel state information, transmitting the bit representation to the controller, and receiving a transmission from the controller. The computing makes use of quasi-tail-biting trellis decoding, and the computing is based on the bit-allocation policy. The transmission makes use of the channel state information transmitted by the communications node. | 01-03-2013 |
Patent application number | Description | Published |
20110054265 | HIGHLY RELIABLE INGESTIBLE EVENT MARKERS AND METHODS FOR USING THE SAME - Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane. | 03-03-2011 |
20110306852 | Pharmaceutical Dosages Delivery System - Pharmaceutical delivery systems for delivering dosages according to the present invention include a carrier component and a cap configured to seal an internal volume of the carrier component, wherein the cap includes a device that produces a unique current signature. Dosages prepared to be delivered according to embodiments of the invention find use in a variety of different applications, including clinical trials. | 12-15-2011 |
20120011699 | HIGH-THROUGHPUT PRODUCTION OF INGESTIBLE EVENT MARKERS - High-throughput ingestible event marker manufacturing systems are provided. The systems include an assembly unit configured to stably associate an ingestible event marker with a carrier to produce a product. Also provided are manufacturing methods to produce such products which include assembling an ingestible event marker with an assembly unit configured to stably associate an ingestible event marker with a carrier. | 01-19-2012 |
20120059257 | Ingestible Event Markers Comprising an Ingestible Component - Ingestible event markers comprising an identifier and an ingestible component are provided. The ingestible component may vary, where ingestible components of interest include osmotic ingestible components, liquid capsules, tablets, multi-layered ingestible component and multi-compartment ingestible components. In some instances, the identifier is mechanically stably associated with the ingestible component. Also provided are systems that include the ingestible event markers, as well as methods of using the ingestible event markers. | 03-08-2012 |
20130144132 | Highly Reliable Ingestible Event Markers and Methods for Using the Same - Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane. | 06-06-2013 |
20140046147 | Pharmaceutical Dosages Delivery System - Pharmaceutical delivery systems for delivering dosages according to the present invention include a carrier component and a cap configured to seal an internal volume of the carrier component, wherein the cap includes a device that produces a unique current signature. Dosages prepared to be delivered according to embodiments of the invention find use in a variety of different applications, including clinical trials. | 02-13-2014 |
Patent application number | Description | Published |
20090149902 | IMPLANTED CARDIAC DEVICE FOR DEFIBRILLATION - An implantable medical device for delivering electrical cardiac therapy includes a first implantable housing containing a battery. There is also a second implantable housing separate from the first implantable housing and containing at least one of: electronic circuitry adapted to evaluate and initiate electrical cardiac therapy, a storage capacitor and an electrode structure comprising a sensing electrode, a pacing electrode and a therapy electrode. The electronic circuit, the storage capacitor or the electrode structure are electrically connected to the battery. Alternatively, there is an implantable medical device for delivering electrical cardiac therapy having an implantable structure containing the following electrically connected components: a battery, electronic circuitry adapted to evaluate and initiate electrical cardiac therapy, a storage capacitor and an electrode structure comprising a sensing electrode, a pacing electrode and a therapy electrode. A method of providing electrical cardiac therapy is also provided. | 06-11-2009 |
20110270052 | Ingestion-Related Biofeedback and Personalized Medical Therapy Method and System - Methods, devices and systems for acquiring information useful to support a patient in implementing and adhering to a medically prescribed therapy plan are provided. The therapy may incorporate biofeedback methods and/or personalized therapy aspects. A method includes steps of receiving, by a receiving device, biometric information associated with an ingestible event marker; analyzing, by a computing device having a microprocessor configured to perform a biometric information analysis, the biometric information; and determining a therapeutic recommendation at least partly on the basis of the analysis and/or integrating biofeedback techniques into patient therapy or activity. A system includes a biometric information module to receive biometric information associated with an ingestible event marker; an analysis module to analyze the biometric information; and a determination module to optionally determine and communicate a therapeutic recommendation at least partly on the basis of the analysis. | 11-03-2011 |
20120215123 | NON-INVASIVE CARDIAC MONITOR AND METHODS OF USING CONTINUOUSLY RECORDED CARDIAC DATA - Embodiments of the invention provide methods of obtaining continuous cardiac information from a mammal. First, attach a self-contained, wearable, portable continuous cardiac monitor to the mammal to create a chamber containing electrodes used to detect cardiac signals from the mammal. Next, continuously detect without analyzing the cardiac signals from the mammal for at least 24 hours. Next, store information related to substantially all detected cardiac signals in the cardiac monitor. | 08-23-2012 |
20130226018 | NON-INVASIVE CARDIAC MONITOR AND METHODS OF USING CONTINUOUSLY RECORDED CARDIAC DATA - Embodiments of the invention provide methods of obtaining continuous cardiac information from a mammal. First, attach a self-contained, wearable, portable continuous cardiac monitor to he mammal to create a chamber containing electrodes used to detect cardiac signals from the mammal. Next, continuously detect without analyzing the cardiac signals from the mammal for at least 24 hours. Next, store information related to substantially all detected cardiac signals in the cardiac monitor. | 08-29-2013 |
20140128935 | IMPLANTED CARDIAC DEVICE FOR DEFIBRILLATION - An implantable medical device for delivering electrical cardiac therapy includes a first implantable housing containing a battery. There is also a second implantable housing separate from the first implantable housing and containing at least one of: electronic circuitry adapted to evaluate and initiate electrical cardiac therapy, a storage capacitor and an electrode structure comprising a sensing electrode, a pacing electrode and a therapy electrode. There is a method of providing electrical cardiac therapy by implanting a first housing containing a battery into a first implantation site within the body. Then, implant a second housing separate from the first housing into a second implantation site within the body. The second housing contains at least one of: electronic circuitry adapted to evaluate and initiate electrical cardiac therapy; a storage capacitor and an electrode structure comprising a sensing electrode, a pacing electrode and a therapy electrode. | 05-08-2014 |
20140203950 | Mobile Communication Device, System, and Method - A mobile device for detecting an electrical signal generated by an ingestible event marker is disclosed. The mobile device includes a detection subsystem to receive an electrical signal generated by an ingestible event marker from a detection arrangement. A processing subsystem is coupled to the detection subsystem to decode the electrical signal. A radio subsystem is configured to transmit the decoded electrical signal to a wireless node. A system includes the mobile device and the detection arrangement. A method includes receiving the electrical signal generated by the ingestible event marker at the mobile device, decoding the electrical signal to extract information associated with the ingestible event marker, and transmitting the information to a wireless node. | 07-24-2014 |
20140334575 | Active Signal Processing Personal Health Signal Receivers - The invention provides a receiver associated with a body, e.g., located inside or within close proximity to a body, configured to receive and decode a signal from an in vivo transmitter which located inside the body. Signal receivers of the invention provide for accurate signal decoding of a low-level signal, even in the presence of significant noise, using a small-scale chip, e.g., where the chip consumes very low power. Also provided are systems that include the receivers, as well as methods of using the same. | 11-13-2014 |
Patent application number | Description | Published |
20090104099 | RICH GAS ABSORPTION APPARATUS AND METHOD - The present invention relates to an apparatus comprising a co-current absorbing unit, a countercurrent absorbing unit, at least one absorbing liquid reservoir, and at least one liquid transferring means. The invention also relates to a method of absorbing a reactive gas and a method of preparing a solution by contacting a reactive gas to a solvent and allowing the reactive gas to react with the solvent. | 04-23-2009 |
20110005914 | Selective dehydrohalogenation of tertiary halogenated hydrocarbons and removal of tertiary halogenated hydrocarbon impurities from a halogenated hydrocarbon product - A process for converting a tertiary halogenated hydrocarbons in a tertiary halogenated hydrocarbon-containing stream to a corresponding unhalogenated or less-halogenated unsaturated hydrocarbon product with the release of hydrogen halide involves contacting the tertiary halogenated hydrocarbon with a sorbent-type dehydrohalogenation catalyst in a reaction zone and optionally passing a stripping gas through the reaction zone to remove vapor phase reaction products from the reaction zone. A process for removing a tertiary chlorinated hydrocarbon impurity from 1,3-dichloro-1-propene involves contacting a mixture containing the 1,3-dichloro-1-propene and the tertiary chlorinated hydrocarbon impurity with a dehydrochlorination catalyst effective to catalyze a conversion of the tertiary chlorinated hydrocarbon impurity to a corresponding unchlorinated or less-chlorinated unsaturated hydrocarbon and hydrogen chloride and distilling the 1,3-dichloro-1-propene to produce a purified cis-1,3-dichloro-1-propene fraction and a purified trans-1,3-dichloro-1-propene fraction. | 01-13-2011 |
20110087055 | PROCESSES FOR THE PRODUCTION OF CHLORINATED AND/OR FLUORINATED PROPENES AND HIGHER ALKENES - The present invention provides continuous, gas phase, free radical processes for the production of chlorinated and/or fluorinated propenes or higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes, wherein wherein at least a portion of any intermediate boiler by-products generated by the process are removed from the process | 04-14-2011 |
20130206578 | SELECTIVE DEHYDROHALOGENATION OF TERTIARY HALOGENATED HYDROCARBONS AND REMOVAL OF TERTIARY HALOGENATED HYDROCARBON IMPURITIES FROM A HALOGENATED HYDROCARBON PRODUCT - A process for converting a tertiary halogenated hydrocarbons in a tertiary halogenated hydrocarbon-containing stream to a corresponding unhalogenated or less-halogenated unsaturated hydrocarbon product with the release of hydrogen halide involves contacting the tertiary halogenated hydrocarbon with a sorbent-type dehydrohalogenation catalyst in a reaction zone and optionally passing a stripping gas through the reaction zone to remove vapor phase reaction products from the reaction zone. A process for removing a tertiary chlorinated hydrocarbon impurity from 1,3-dichloro-1-propene involves contacting a mixture containing the 1,3-dichloro--propene and the tertiary chlorinated hydrocarbon impurity with a dehydrochlorination catalyst effective to catalyze a conversion of the tertiary chlorinated hydrocarbon impurity to a corresponding unchlorinated or less-chlorinated unsaturated hydrocarbon and hydrogen chloride and distilling the 1,3-dichloro-1-propene to produce a purified cis-1,3-dichloro- 1-propene fraction and a purified trans-1,3-dichloro-1-propene fraction. | 08-15-2013 |
20130206579 | SELECTIVE DEHYDROHALOGENATION OF TERTIARY HALOGENATED HYDROCARBONS AND REMOVAL OF TERTIARY HALOGENATED HYDROCARBON IMPURITIES FROM A HALOGENATED HYDROCARBON PRODUCT - A process for converting a tertiary halogenated hydrocarbons in a tertiary halogenated hydrocarbon-containing stream to a corresponding unhalogenated or less-halogenated unsaturated hydrocarbon product with the release of hydrogen halide involves contacting the tertiary halogenated hydrocarbon with a sorbent-type dehydrohalogenation catalyst in a reaction zone and optionally passing a stripping gas through the reaction zone to remove vapor phase reaction products from the reaction zone. A process for removing a tertiary chlorinated hydrocarbon impurity from 1,3-dichloro-1-propene involves contacting a mixture containing the 1,3-dichloro-1-propene and the tertiary chlorinated hydrocarbon impurity with a dehydrochlorination catalyst effective to catalyze a conversion of the tertiary chlorinated hydrocarbon impurity to a corresponding unchlorinated or less-chlorinated unsaturated hydrocarbon and hydrogen chloride and distilling the 1,3-dichloro-1-propene to produce a purified cis-1,3-dichloro-1-propene fraction and a purified trans-1,3-dichloro-1-propene fraction. | 08-15-2013 |
20150057455 | FLASH EVAPORATION FOR PRODUCT PURIFICATION AND RECOVERY - Methods and systems for producing high purity 3-hydroxypropionic acid (3-HP) from an aqueous medium, such as a fermentation broth, are described. Aqueous 3-HP solution can be purified by flash evaporation wherein the 3-HP is vaporized at an elevated temperature without conversion to acrylic acid. This process can be integrated with downstream processes for producing other chemical and consumer products. | 02-26-2015 |
Patent application number | Description | Published |
20120116123 | PROCESS FOR SEPARATING ONE OR MORE ALIPHATIC DIAMINES FROM REDUCTIVE AMINATION REACTION SOLVENTS AND IMPURITIES - The instant invention provides a process for separating one or more aliphatic diamines from reductive amination reaction solvents and impurities, and aliphatic diamines obtained via such a process. The process for separating one or more aliphatic diamines from reductive amination reaction solvents and impurities according to the instant invention comprises the steps of: (1) feeding one or more cycloaliphatic cyanoaldehydes, hydrogen, ammonia, and optionally one or more solvents into a continuous reductive amination reactor system; (2) contacting said one or more cycloaliphatic cyanoaldehydes, hydrogen, and ammonia with each other in the presence of one or more heterogeneous metal based catalyst systems at a temperature in the range of from 80° C. to about 160° C. and a pressure in the range of from 700 to 3500 psig; (3) thereby forming a product mixture comprising one or more cycloaliphatic diamines, optionally one or more bicyclic by-products, optionally one or more cycloaliphatic aminonitriles, optionally one or more cycloaliphatic aminoalcohols, optionally one or more oligomeric by-products, ammonia, water, hydrogen, and optionally one or more solvents; (4) removing said product mixture from the reactor system; (5) removing at least a portion of said ammonia, said hydrogen, or mixture thereof from said product mixture via distillation; (6) removing at least a portion of said water and said one or more optional solvents via distillation; (7) removing at least a portion of one or more optional bicyclic by-products via distillation; (8) removing one or more optional cycloaliphatic aminonitriles, one or more optional cycloaliphatic aminoalcohols, one or more optional oligomeric by-products via distillation; and (9) thereby separating said one or more cycloaliphatic diamines from said product mixture. | 05-10-2012 |
20140031595 | PROCESSES FOR THE PRODUCTION OF CHLORINATED AND/OR FLUORINATED PROPENES AND HIGHER ALKENES - The present invention provides continuous, gas phase, free radical processes for the production of chlorinated and/or fluorinated propenes or higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes, wherein wherein at least a portion of any intermediate boiler by-products generated by the process are removed from the process | 01-30-2014 |